Skip to Content

Curative Biosciences Inc CBDX

Morningstar Rating
$0.00 0.00 (66.67%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CBDX is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$1.20
Uncertainty
Extreme
1-Star Price
$1.81
5-Star Price
$8.87
Economic Moat
Hrm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CBDX is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.01 / $0.10
Market Cap
$15,787.35
Volume/Avg
25,000 / 15,000

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
6

Valuation

Metric
CBDX
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
CBDX

Financial Strength

Metric
CBDX
Quick Ratio
0.00
Current Ratio
0.00
Interest Coverage
Quick Ratio
CBDX

Profitability

Metric
CBDX
Return on Assets (Normalized)
−12,044.82%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
CBDX
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
FnytwdwlkMmmt$82.1 Bil
Merck KGaA ADR
MKKGY
RhfpcgvmVntjh$75.2 Bil
Haleon PLC ADR
HLN
BnhlcvmSwzq$41.4 Bil
Viatris Inc
VTRS
KmkdxqbpFbg$14.4 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
KgxyfsvjFhy$13.7 Bil
Catalent Inc
CTLT
HywjjhvtJrhljkz$10.6 Bil
Perrigo Co PLC
PRGO
RkntjmsbJbzgx$3.8 Bil
Prestige Consumer Healthcare Inc
PBH
LzvftdtnHrrntc$3.5 Bil
Curaleaf Holdings Inc
CURLF
RcyxstgktThbk$3.0 Bil
Green Thumb Industries Inc
GTBIF
RzvmjgpqCyshw$2.7 Bil

Sponsor Center